# Myo-inositol Plus Alpha-lactalbumin in PCOS Myo-inositol-resistant Patients

> **NCT03667443** · NA · COMPLETED · sponsor: **Lo.Li.Pharma s.r.l** · enrollment: 50 (actual)

## Conditions studied

- PCOS
- Myo-inositol-resistance

## Interventions

- **DIETARY_SUPPLEMENT:** Myo-inositol + folic a. + α-lactalbumin
- **DIETARY_SUPPLEMENT:** Myo-inositol + folic a.

## Key facts

- **NCT ID:** NCT03667443
- **Lead sponsor:** Lo.Li.Pharma s.r.l
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-13
- **Primary completion:** 2022-10-26
- **Final completion:** 2022-12-19
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2025-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03667443

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03667443, "Myo-inositol Plus Alpha-lactalbumin in PCOS Myo-inositol-resistant Patients". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03667443. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*